首都医科大学学报 ›› 2026, Vol. 47 ›› Issue (2): 346-352.doi: 10.3969/j.issn.1006-7795.2026.02.016

• 临床研究 • 上一篇    下一篇

嗜肺军团菌肺炎临床特征分析及治疗策略

何志雄,刘萍*   

  1. 长沙市第一医院呼吸与危重症医学科, 长沙  410000
  • 收稿日期:2025-09-09 修回日期:2026-01-19 出版日期:2026-04-21 发布日期:2026-04-21
  • 通讯作者: 刘萍 E-mail:349221608@qq.com
  • 基金资助:
    湖南省自然科学基金项目(2022JJ80102)、长沙市科技局计划项目(kzd22062)、湖南省卫生健康委员会基金项目(C20180386)。

Clinical characteristics analysis and treatment strategies for Legionella pneumophila pneumonia

He Zhixiong, Liu Ping*   

  1. Department of Respiratory and Critical Care Medicine, The First Hospital of Changsha, Changsha 410000, China
  • Received:2025-09-09 Revised:2026-01-19 Online:2026-04-21 Published:2026-04-21
  • Supported by:
    This study was supported by the Hunan Natural Science Foundation(2022JJ80102),Changsha Science and Technology Program(kzd22062),Hunan Provincial Health Commission(C20180386).

摘要: 目的  本研究旨在总结与嗜肺军团菌肺炎相关的临床特征和结局,从而提高临床医生对该疾病的认识。方法  采用回顾性分析方法,对长沙市第一医院2021年10月至2024年7月期间诊断为嗜肺军团菌肺炎患者的临床特征及治疗预后结局进行分析。结果  本研究共纳入71例患者,其中男性50例,女性21例,平均年龄为(62.6±15.9)岁,其中包括重症病例20例,非重症病例51例。主要临床症状包括咳嗽(n=58)、咳痰(n=51)、呼吸困难(n=34)、发热(n=33)、头痛(n=13)、疲劳(n=9)和肌痛(n=8)。呼吸困难是唯一在重症与非重症肺炎组间具有显著差异的临床症状。与非重症组相比,重症肺炎组的降钙素原(procalcitonin, PCT)、C反应蛋白(C-reactive protein, CRP)、D-二聚体、肌酸激酶(creatine kinase, CK)及肌酸激酶同工酶(CK-myocardial band, CK-MB)浓度均显著升高(P<0.05)。相反,重症组的淋巴细胞计数、血小板(platelet, PLT)计数和血清白蛋白浓度显著降低。常见胸部计算机断层扫描(computed tomography, CT)表现包括片状高密度影(n=62)、肺小结节(n=23)和胸腔积液(n=18)。主要并发症包括电解质紊乱(n=26)、I型呼吸衰竭(n=22)、急性肝损伤(n=20)、脓毒症(n=13)、急性肾功能损害(n=11)、脓毒症休克(n=6)、多器官功能障碍综合征(multiple organ dysfunction syndrome,MODS)(n=4)和急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)(n=2)。重症监护室入住率为22.5%,住院期间总病死率为4.2%(n=3)。83.1%的患者接受了喹诺酮类药物治疗。其中,38例患者仅使用喹诺酮类药物,3例患者仅使用阿奇霉素,其余患者则采用联合用药方案。在治疗过程中,共有7例患者接受了有创机械通气治疗,11例患者接受了无创通气治疗。重症肺炎组中,有3例患者因败血症和多器官功能衰竭而死亡。 结论  嗜肺军团菌肺炎的主要临床表现包括咳嗽、咳痰、呼吸困难(重症患者尤为明显)、发热以及肺部高密度实变影。若嗜肺军团菌感染未能及时诊断治疗,患者可能发展为重症肺炎、多器官功能衰竭,甚至导致死亡。在治疗方面,早期应用喹诺酮类药物或联合其他药物治疗对嗜肺军团菌肺炎具有显著的临床疗效。

关键词: 嗜肺军团菌, 肺炎, 临床特征, 治疗策略, 喹诺酮, 阿奇霉素

Abstract: Objective  To summarize the clinical characteristics and outcomes associated with Legionella pneumophila pneumonia, thereby enhancing clinicians' understanding of this disease. Methods  A retrospective analysis of the clinical characteristics and prognostic outcomes of patients diagnosed with Legionella pneumophila pneumonia at The First Hospital of Changsha from October 2021 to July 2024. Results  The study included 50 male and 21 female participants, with an average age of (62.6±15.9) years. Common symptoms included cough (n =58), expectoration (n= 51), Dyspnea (n=34), fever (n=33), headache (n =13), fatigue (n= 9), and myalgia (n=8). Dyspnea was the only clinical symptom that showed a significant difference between the severe and non-severe pneumonia groups. The levels of procalcitonin (PCT), C-reactive protein (CRP), D-dimer, creatine kinase (CK), and CK-myocardial band (CK-MB) were significantly higher in the severe pneumonia group compared to the non-severe group. Conversely, lymphocyte count, platelet (PLT) count, and albumin levels were significantly lower in the severe group (P<0.05). Common computed tomography (CT) manifestations included flake-like high-density shadows (n = 62, 87.3%), small pulmonary nodules (n = 23, 32.4%), pleural effusion (n=18, 25.4%). Common complications included electrolyte disorders (n=26), type I respiratory failure (n=22), acute liver injury (n=20), sepsis (n=13), acute renal impairment (n=11), septic shock (n=6), multiple organ dysfunction syndrome (MODS) (n=4), and acute respiratory distress syndrome (ARDS) (n=2). The rate of intensive care unit (ICU) admission was 22.5% and the overall mortality rate during hospital was 4.2%(n=3). The majority of patients received treatment with quinolones (59 out of 71, 83.1%). Specifically, 38 patients were treated exclusively with quinolones, while 3 patients received azithromycin alone. A total of 7 patients received invasive ventilation treatment, while 11 patients were treated with non-invasive ventilation. Unfortunately, 3 patients in the severe pneumonia group died due to sepsis and multiple organ failure. Conclusion  If Legionella pneumophila infections are not diagnosed promptly, patients may experience severe pneumonia, multiple organ failure, or even fatal outcomes. The early initiation of quinolones or combination therapy with other medications has shown significant therapeutic benefits for patients suffering from Legionella pneumophila pneumonia.

Key words: Legionella pneumophila, pneumonia, clinical characteristics, treatment strategies, quinolone, azithromycin.

中图分类号: